Jagsonpal Pharmaceuticals Ltd has informed BSE that Meeting of Board of Directors of the Company will be held on October 19, 2021, inter alia, to consider and approve:<BR><BR>1. The Standalone Un-Audited Financial Results of the Company for the quarter and half year ended September 30, 2021;<BR><BR>2. The Limited Review Report on Un-Audited Financial Results of the company for the quarter and half year ended September 30, 2021;<BR><BR>3. The declaration of Interim Dividend, if any;
|